Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction

NCT07192341 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT07192341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07192341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction
Lead sponsor
Kafrelsheikh University
Phase
Not applicable
Overall status
Recruiting
Start date
September 27, 2025
Completion date
February 1, 2026
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, prosthetic heart valve, reduced ejection fraction, sacubitril/valsartan